Adagio Medical Holdings, Inc.
ADGM
Analytical Summary
Adagio Medical Holdings, Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Debt to Equity. The fundamentals warrant careful consideration of downside risks.
4-Year Financial Trajectory
AnnualBullish Indicators
- No bullish signals detected.
Bearish Risks
- Debt to EquityDebt to Equity is concerning (bottom quartile)
- Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile
Health Breakdown
Dividend History
Dividend / share · sourced from SEC filingsStatement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
| Metric | FY 2025 Dec 31, 2025 10-K ↗ | FY 2024 Dec 31, 2024 10-K ↗ | FY 2023 Dec 31, 2023 10-K ↗ | FY 2022 Dec 31, 2022 10-K ↗ |
|---|---|---|---|---|
| Effective Tax Rate (%) (%) |
0.0%
Excellent
Excellent
Actual taxes paid relative to pre-tax income
Optimal:
15-25%
|
— |
0.0%
Excellent
Excellent
Actual taxes paid relative to pre-tax income
Optimal:
15-25%
|
— |
| FCF / Net Income (x) |
0.77x
Caution
Caution
Free cash flow relative to reported net income
Optimal:
> 1x
|
— |
0.71x
Caution
Caution
Free cash flow relative to reported net income
Optimal:
> 1x
|
— |
| Metric | FY 2025 Dec 31, 2025 10-K ↗ | FY 2024 Dec 31, 2024 10-K ↗ | FY 2023 Dec 31, 2023 10-K ↗ | FY 2022 Dec 31, 2022 10-K ↗ |
|---|---|---|---|---|
| Return on Invested Capital (%) |
-65.5%
Weak
Weak
Return earned on debt + equity capital invested
Optimal:
> 10%
|
— |
29.8%
Excellent
Excellent
Return earned on debt + equity capital invested
Optimal:
> 10%
|
— |
| Return on Capital (%) (%) |
-50.6%
Weak
Weak
Operating profit relative to total assets
Optimal:
> 10%
|
— |
-409.4%
Weak
Weak
Operating profit relative to total assets
Optimal:
> 10%
|
— |
| Return on Common Equity (%) (%) |
-202.3%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-1448%)
|
— |
27.7%
Excellent
Excellent
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Above avg (+85%)
|
— |
| Metric | FY 2025 Dec 31, 2025 10-K ↗ | FY 2024 Dec 31, 2024 10-K ↗ | FY 2023 Dec 31, 2023 10-K ↗ | FY 2022 Dec 31, 2022 10-K ↗ |
|---|---|---|---|---|
| Debt to Equity (x) |
1.70x
Weak
↑
Weak
Improving
Total debt relative to shareholder equity
Optimal:
< 0.6x
vs Sector:
Above avg (+183%)
|
-0.12x
Excellent
Excellent
Total debt relative to shareholder equity
Optimal:
< 0.6x
vs Sector:
Below avg (-119%)
|
-0.29x
Excellent
Excellent
Total debt relative to shareholder equity
Optimal:
< 0.6x
vs Sector:
Below avg (-148%)
|
— |
| Interest Coverage (x) | — | — |
-134.34x
Weak
Weak
Operating income divided by interest expense
Optimal:
> 5x
|
— |
| Net Debt (USD) | $3.94M | $-3.41M | $36.88M | — |
| Debt / EBITDA (x) |
-1.01x
Excellent
Excellent
Debt relative to earnings before interest, taxes, depreciation
Optimal:
< 2x
|
— |
-1.40x
Excellent
Excellent
Debt relative to earnings before interest, taxes, depreciation
Optimal:
< 2x
|
— |
| Metric | FY 2025 Dec 31, 2025 10-K ↗ | FY 2024 Dec 31, 2024 10-K ↗ | FY 2023 Dec 31, 2023 10-K ↗ | FY 2022 Dec 31, 2022 10-K ↗ |
|---|---|---|---|---|
| Sales/Revenue/Turnover (USD) | $0.00 | — | $300.00K | — |
| Depreciation Expense (USD) | $970.00K | — | $532.00K | — |
| Net Income, GAAP (USD) | $-25.08M | — | $-36.59M | — |
| Operating Cash Flow (USD) | $-19.01M | — | $-25.65M | — |
Secondary lens
Benchmark Lens
Compare ADGM against peers after checking the statement evidence.
Open lens
Benchmark Lens
Compare ADGM against peers after checking the statement evidence.
Signals
Key bullish and bearish indicators for ADGM
No bullish signals detected
Debt to Equity is concerning (bottom quartile)
Return on Common Equity (%) is in the bottom quartile
Percentile Rankings
How ADGM compares to all companies
Peer Comparison
ADGM vs similar peers
Compare ADGM with peers
Stack ADGM against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced 1 week ago 4 years · 14 quarters